Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_30606574 Show fit | 1.21 |
ENST00000295754.10
ENST00000359013.4 |
transforming growth factor beta receptor 2 |
|
chr4_-_108168919 Show fit | 1.20 |
ENST00000265165.6
|
lymphoid enhancer binding factor 1 |
|
chr16_-_88941198 Show fit | 0.96 |
ENST00000327483.9
ENST00000564416.1 |
CBFA2/RUNX1 partner transcriptional co-repressor 3 |
|
chr12_+_64610458 Show fit | 0.88 |
ENST00000542104.6
|
Ras association domain family member 3 |
|
chr17_-_30824665 Show fit | 0.78 |
ENST00000324238.7
|
cytokine receptor like factor 3 |
|
chr12_+_94148553 Show fit | 0.78 |
ENST00000258526.9
|
plexin C1 |
|
chr1_-_30757767 Show fit | 0.77 |
ENST00000294507.4
|
lysosomal protein transmembrane 5 |
|
chr12_+_59689337 Show fit | 0.75 |
ENST00000261187.8
|
solute carrier family 16 member 7 |
|
chr2_-_207166818 Show fit | 0.74 |
ENST00000423015.5
|
Kruppel like factor 7 |
|
chr15_+_74541200 Show fit | 0.72 |
ENST00000622429.1
ENST00000346246.10 |
AT-rich interaction domain 3B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 1.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 1.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.8 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.5 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.2 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 1.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 0.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 0.7 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.5 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.8 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |